Showing results (141-150 of 201) with videos related to
Sort By:
Pageof 21
Journal of Geriatric Oncology|February 11, 2015
Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumorsAjeet Gajra, Heidi D Klepin, Tao Feng, et al.Journal of Geriatric Oncology|May 21, 2016
Chemotherapy-related cognitive impairment in older patients with cancerKah Poh Loh, Michelle C Janelsins, Supriya G Mohile, et al.Journal of Geriatric Oncology|November 19, 2016
Association between renal function and chemotherapy-related toxicity in older adults with cancerLindsay L Peterson, Arti Hurria, Tao Feng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2011
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter studyArti Hurria, Kayo Togawa, Supriya G Mohile, et al.Annals of Surgical Oncology|November 25, 2025
Outcomes of Patients Undergoing Sentinel Lymph Node Biopsy for Merkel Cell CarcinomaEdmund K Bartlett, Hannah L Kalvin, Christopher A Barker, et al.NPJ Precision Oncology|March 25, 2025
Immunologic correlates in a CIC::DUX4 fusion-positive sarcoma responsive to dual immune checkpoint blockadeOlayode O Babatunde, Sara Coca Membribes, Cristina Anthonescu, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 30, 2018
Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research GroupTanya M Wildes, Ronald J Maggiore, William P Tew, et al.Current Oncology (Toronto, Ont.)|August 27, 2025
Using Audit to Improve End-of-Life Care in a Tertiary Cancer CentreConor D Moloney, Hailey K Carroll, Elaine Cunningham, et al.Irish Journal of Medical Science|May 28, 2024
The impact of expanded access programs for systemic anticancer therapy in an Irish cancer centreTimothy K Cronin, Cian Ronayne, Niamh O'Donovan, et al.Cancer Research Communications|March 17, 2023
Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional ChondrosarcomaJosephine Kam Tai Dermawan, Khedoujia Nafa, Abhinita Mohanty, et al.Pageof 21